Dr. Kiran K. Yalamanchili
Claim this profileCovenant Medical Center-Lakeside
Area of expertise
Lung Cancer
Kiran K. Yalamanchili has run 2 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Kiran K. Yalamanchili has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Covenant Medical Center-Lakeside
Joe Arrington Cancer Research And Treatment Center
Clinical Trials Kiran K. Yalamanchili is currently running
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting
1 award
Phase 2 & 3
21 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting
1 award
Phase 2
17 criteria
More about Kiran K. Yalamanchili
Clinical Trial Related
6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Kiran K. Yalamanchili has experience with
- Cisplatin
- Atezolizumab
- Intensity-Modulated Radiation Therapy
- Nivolumab
- Ipilimumab
- Lenvatinib
Breakdown of trials Kiran K. Yalamanchili has run
Lung Cancer
Non-Small Cell Lung Cancer
Liver Cancer
Burkitt Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kiran K. Yalamanchili specialize in?
Kiran K. Yalamanchili focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved ALK negative patients, or patients who are PD-L1 positive.
Is Kiran K. Yalamanchili currently recruiting for clinical trials?
Yes, Kiran K. Yalamanchili is currently recruiting for 3 clinical trials in Lubbock Texas. If you're interested in participating, you should apply.
Are there any treatments that Kiran K. Yalamanchili has studied deeply?
Yes, Kiran K. Yalamanchili has studied treatments such as Cisplatin, Atezolizumab, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Kiran K. Yalamanchili?
Apply for one of the trials that Kiran K. Yalamanchili is conducting.
What is the office address of Kiran K. Yalamanchili?
The office of Kiran K. Yalamanchili is located at: Covenant Medical Center-Lakeside, Lubbock, Texas 79410 United States. This is the address for their practice at the Covenant Medical Center-Lakeside.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.